...
首页> 外文期刊>Seminars in ophthalmology >Short-duration focal pattern grid photocoagulation for macular edema secondary to branch retinal vein occlusion
【24h】

Short-duration focal pattern grid photocoagulation for macular edema secondary to branch retinal vein occlusion

机译:短期病灶模式网格光凝治疗视网膜分支静脉阻塞继发的黄斑水肿

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Purpose: To evaluate the safety, functional, and anatomical outcomes of short-duration pattern scanning laser (PASCAL) macular photocoagulation in the treatment of macular edema related to branch retinal vein occlusion (BRVO). Methods: Consecutive retrospective analysis of visual acuity (VA), optical coherence tomography (OCT), and adverse events from eyes treated with PASCAL macular photocoagulation for BRVO-related macular edema. Two-tailed paired t-tests were used to compare pre- and post-treatment VA and central retinal thickness (CRT). Results: A total of 35 eyes from 35 patients and 18 eyes from 18 patients met study criteria for VA and OCT analysis, respectively. All treatments were delivered with the same PASCAL photocoagulation unit. Mean laser settings were 133-m spot size, 15-millisecond pulse duration, 250-mW power, and fluence of 29 J/cm 2 with an average of 1.4 treatments and 335 shots per patient. Adjunct treatment with intravitreal anti-VEGF injections and pan-retinal photocoagulation was administered in 27 and 16 eyes, respectively. At an average follow-up of 12 months (range 343 months) post-treatment, no laser-related ocular complications were observed. Visual acuity was not significantly changed (p0.07), although the number of patients with vision better than 20/40 doubled following treatment. CRT was reduced by an average of 110 m (p0.0009). Conclusion: Short-duration PASCAL macular photocoagulation appears to be a safe treatment option that results in significant anatomical improvement in macular edema related to BRVO.
机译:目的:评价短时模式扫描激光(PASCAL)黄斑光凝治疗与视网膜分支静脉阻塞(BRVO)相关的黄斑水肿的安全性,功能和解剖学结果。方法:连续回顾性分析视力(VA),光学相干断层扫描(OCT)和PASCAL黄斑光凝治疗BRVO相关性黄斑水肿所致眼睛的不良事件。使用两尾成对的t检验比较治疗前后的VA和视网膜中央厚度(CRT)。结果:来自35例患者的35眼和来自18例患者的18眼分别满足VA和OCT分析的研究标准。所有治疗均使用相同的PASCAL光凝装置进行。平均激光设置为133 m的光斑大小,15毫秒的脉冲持续时间,250 mW的功率以及29 J / cm 2的注量,每位患者平均进行1.4次治疗和335次注射。分别在27只和16只眼中进行玻璃体内抗VEGF注射和全视网膜光凝的辅助治疗。治疗后平均随访12个月(343个月),未观察到激光相关的眼部并发症。尽管视力好于20/40的患者人数在治疗后增加了一倍,但视力没有明显变化(p0.07)。 CRT平均减少110 m(p0.0009)。结论:短期PASCAL黄斑光凝似乎是一种安全的治疗选择,可显着改善与BRVO相关的黄斑水肿的解剖结构。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号